Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan

Journal of the Chinese Medical Association

Volumn 66, Issue 1, 2003, Pages 51-56

  Chang, Hung Rong ^c   Cheng, Chi Hung ^a,b,c   Shu, Kuo Hsiung ^a,b,c   Chen, Chen Hsu ^a   Lian, Jong Da ^c   Wu, Ming Yu ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiotensinogen; Angiotensins; Diabetic nephropathy; Polymorphism; Receptor, angiotensin

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ANGIOTENSIN 1 RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT MUTATION; POLYMERASE CHAIN REACTION; TAIWAN; CHRONIC KIDNEY FAILURE; GENETICS; MIDDLE AGED;

ADULT; AGED; ANGIOTENSINOGEN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN;

EID: 0038319133     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hollenberg NK, Raij L. Angiotensin-converting enzyme inhibition and renal protection: An assessment of implications for therapy. Arch Intern Med 1993;153:2426-35.
2. Beaufils M. Angiotensin-converting enzyme inhibition and diabetic nephropathy. J Cardiovasc Pharmacol 1992;19:S33-8.
3. Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. Br Med J 1991;303:81-7.
4. Gumprechi J, Zychma MJ, Grzeszcak W, Zukowska-Szcechowska E. Angitotensin-converting enzyme gene insertion/deletion and agniotensinogen M235T polymorphisms: risk of chronic renal failure. Kidney Int 2000;58:513-9.
5. Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P. Genetic Polymorphisms of the rennin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 2001;60:46-54.
6. Cong ND, Hamaguchi K, Saikawa T, Hara M, Sakata T. A polymorphism of angiotensinogen gene codon 174 and coronary artery disease in Japanese subjects. Am J Med Sci 1998;316:339-44.
7. Wang WY, Zee RY, Morris BJ. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 1997;51:31-4.
8. Ward R. Family aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. Vol. 1. New York; Raven Press, 1990:81-100.
9. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
10. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
11. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-33.
12. Hingorani AD, Brown MJ. A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene. Biochem Biophys Res Commun 1995;213:725-9.
13. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SL, Gibson SP, Khatoon A, et al. Examination of two genetic polymorphisms within renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996;139: 1108-14.
14. Aurell M, Bjorck S. Determinants of progressive renal disease in diabetes mellitus. Kidney Int 1992;36:S38-42.
15. Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, et al. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrol Dial Transplant 1996;11:1755-61.
16. Nelson RG, Pettitt DJ, Baird HR, Charles MA, Liu QZ, Bennett PH, et al. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993;36:998-1001.
17. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, et al. Angiotensinogen gene polymorphism in IDDM patients with diabetic nephropathy. Diabetes 1996; 45:367-9.
18. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996;39:97-102.
19. Oh TG, Shin CS, Park KS, Kim SY, Cho BY, Lee HK, et al. Relationships between angiotensin I-converting enzyme gene polymorphism and renal complications in Korean IDDM patients. Korean J Intern Med 1996;11:133-7.
20. Schmidt S, Strojek K, Grzeszczak W, Bergis K, Ritz E. Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1997;12:427-9.
21. Ohno T, Kawazu S, Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1996;45:218-22.
22. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996;50:657-64.
23. Jeffers BW, Estacio RO, Raynolds MV, Schrier RW. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 1997;52:473-7.
24. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 2000;15:1008-13.
25. Panagiotopoulos S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ, Jerums G. Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications 1995;9:272-6.
26. Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years. Nephron 1998;80:17-24.
27. Tomino Y, Makita Y, Shike T, Gohda T, Haneda M, Kikkawa R, et al. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 1999;82:139-44.
28. Wong TY, Chan JC, Poon E, Li PK. Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. Am J Kidney Dis 1999;33:1064-70.
29. Walker WG, Whelton PK, Saito H, Russell RP, Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979;1:287-91.
30. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al. M235T variant of the human angiotensinogen in unselective hypertensive patients. J Hypertens 1993; 11(suppl 5):80-1.
31. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
32. Chowdhury TA, Dyer PH, Kumar S, Gough SC, Gibson SP, Rowe BR, et al. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus. Diabet Med 1997;14: 837-40.
33. Yudkin JS, Andres C, Mohamed-Ali V, Gould M, Panahloo A, Haines AP, et al. The angiotensin-converting enzyme gene and the angiotensin II type I receptor gene as candidate genes for microalbuminuria: A study in nondiabetic and non-insulin-dependent diabetic subjects. Arterioscler Thromb Vasc Biol 1997;17:2188-91.